Results 131 to 140 of about 36,891 (208)

Extended treatment for venous thromboembolism: Is direct oral anticoagulant dose-reduction better for all? [PDF]

Hemasphere
Lauw MN, Middeldorp S, Carrier M.
europepmc   +1 more source

Relevance and limitations of clinical follow-up in a pharmacokinetic study on direct oral anticoagulants. [PDF]

Front Pharmacol
Terrier J, Gosselin P, Combescure C, Fontana P, Daali Y, Reny JL.   +5 more
europepmc   +1 more source

Trend of Reported Bleeding in Warfarin Compared with Direct Oral Anticoagulants in Japan. [PDF]

Drug Healthc Patient Saf
Takami A, Terashima G, Tajima T, Yamashita K, Igarashi A.   +4 more
europepmc   +1 more source

Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients. [PDF]

Clin Pharmacokinet
Goldstein R, Sandouka K, Zighan L, Ya'ari S, Bialer M, Muszkat M.   +5 more
europepmc   +1 more source

Development of a limited sampling strategy for apixaban area under the curve estimation in elderly patients with non-valvular atrial fibrillation. [PDF]

BMC Geriatr
Sarppreuttikun P, Singhan W, Ariyachaipanich A, Jedsadayanmata A, Lin SY, Katavetin P, Vadcharavivad S.   +6 more
europepmc   +1 more source

Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001. [PDF]

Res Pract Thromb Haemost
Nagy M, Gomes T, van Oerle R, Hacking TM, Magdelijns FJH, Henskens YMC, Reitsma P, Short G, Spronk HMH, Verhoef D.   +9 more
europepmc   +1 more source

Protocol for a phase 3, active (warfarin) controlled, randomized, double-blind, parallel-arm study to evaluate efficacy and safety of apixaban in preventing stroke and systemic embolism in patients with nonvalvular atrial fibrillation [PDF]

, 2015
Παγκαλίδου, Ειρήνη
core   +1 more source

Patient perspectives on post-operative direct oral anticoagulant for venous thromboembolism prevention in patients with gynecologic cancers undergoing laparotomy. [PDF]

Gynecol Oncol Rep
Black KA, Mateshaytis J, Sevick L, Rogers J, Bisch SP, Flasha P, Pin S.   +6 more
europepmc   +1 more source

Kosteneffektivität von Apixaban zur Verhinderung von Schlaganfällen bei Vorhofflimmern in Deutschland [PDF]

, 2013

core   +1 more source

Venous Thromboembolism Management and Anticoagulation Opportunities in Cancer Patients. [PDF]

Eur Cardiol
Szmit S, Krzakowski M, Kowalski DM, Zaborowska-Szmit M.   +3 more
europepmc   +1 more source